SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lakefront Biotherapeutics Announces ASH Poster Presentation

The company says gamgertamig data from ongoing Phase 1b studies suggest potential to retain remission after B cell re...

LKFT

Related stories